|
|||||
|
|
The appropriate use criteria: Improvements for its integration into real world clinical practice |
|
| Authors: | Lloyd W Klein MD Jacqueline Tamis-Holland MD Ajay J Kirtane MD SM H Vernon Anderson MD Joaquin Cigarroa MD Peter L Duffy MD James Blankenship MD MACC C. Michael Valentine MD MACC Frederick GP Welt MD For The AUC Workgroup of the ISLC Endorsed by the Interventional Section Leadership Council American College of Cardiology |
| Affiliation: | 1. Cardiology Section, University of California, San Francisco, California, USA;2. Department of Cardiovascular Diseases, Mount Sinai St. Luke's Hospital, New York, New York, USA;3. Columbia University Irving Medical Center/New York-Presbyterian Hospital, Cardiovascular Research Foundation, New York, New York, USA;4. Cardiology Division, University of Texas Health Science Center, Houston, Texas, USA;5. Cardiovascular Division, Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland, Oregon, USA;6. Reid Heart Center, First Health of the Carolinas, Pinehurst, North Carolina, USA;7. Geisinger Medical Center, Danville, Pennsylvania, USA;8. Stroobants Cardiovascular Group, Lynchburg, Virginia, USA;9. Division of Cardiology, University of Utah Health, Salt Lake City, Utah, USA |
| Abstract: | The purpose of this position statement is to suggest ways in which future appropriate use criteria (AUC) for coronary revascularization might be restructured to: (1) incorporate improvement in quality of life and angina relief as primary goals of therapy, (2) integrate the findings of recent trials into quality appraisal, (3) employ the combined information of the coronary angiogram and invasive physiologic measurements together with the results of stress test imaging to assess risk, and (4) recognize the essential role that patient preference plays in making individualized therapeutic decisions. The AUC is a valuable tool within the quality assurance process; it is vital that interventionists ensure that percutaneous coronary intervention case selection is both evidence-based and patient oriented. Appropriate patient selection is an important quality indicator and adherence to evidence-based practice should be one metric in a portfolio of process and outcome indicators that measure quality. |
| Keywords: | Appropriate use Coronary PCI Quality |